Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stevens

Showing results (261-270 of 295) with videos related to

Pageof 30
Sort By:
The Journal of Infectious Diseases|July 13, 2016
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan AfricaT Sonia Boender, Raph L Hamers, Pascale Ondoa, et al.
Clinical Chemistry|May 26, 2025
Full-Length Clonal Immunoglobulin Rearrangements in cfDNA: Improved Recovery and SequencingRena R Xian, Prisca Mbonu, Lisa M Haley, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
AIDS (London, England)|March 17, 2018
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan AfricaStefanie Kroeze, Pascale Ondoa, Cissy M Kityo, et al.
Plos One|May 1, 2008
Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trialsWendy Stevens, Anatoli Kamali, Etienne Karita, et al.
Blood Advances|August 2, 2021
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based studyMirian Brink, Xaver U Kahle, Joost S P Vermaat, et al.
Vaccine|January 26, 2007
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicityBarry S Peters, Walter Jaoko, Eftyhia Vardas, et al.
Southern African Journal of HIV Medicine|March 24, 2018
South African HIV self-testing policy and guidance considerationsFrancois Venter, Mohammed Majam, Lauren Jankelowitz, et al.
AIDS Research and Human Retroviruses|November 25, 2010
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern AfricaMatt A Price, Carole L Wallis, Shabir Lakhi, et al.
Histopathology|February 28, 2023
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortiumYasodha Natkunam, Daphne de Jong, Pedro Farinha, et al.
Pageof 30

Showing results (261-270 of 295) with videos related to

Sort By:
Pageof 30
The Journal of Infectious Diseases|July 13, 2016
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan AfricaT Sonia Boender, Raph L Hamers, Pascale Ondoa, et al.
Clinical Chemistry|May 26, 2025
Full-Length Clonal Immunoglobulin Rearrangements in cfDNA: Improved Recovery and SequencingRena R Xian, Prisca Mbonu, Lisa M Haley, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
AIDS (London, England)|March 17, 2018
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan AfricaStefanie Kroeze, Pascale Ondoa, Cissy M Kityo, et al.
Plos One|May 1, 2008
Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trialsWendy Stevens, Anatoli Kamali, Etienne Karita, et al.
Blood Advances|August 2, 2021
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based studyMirian Brink, Xaver U Kahle, Joost S P Vermaat, et al.
Vaccine|January 26, 2007
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicityBarry S Peters, Walter Jaoko, Eftyhia Vardas, et al.
Southern African Journal of HIV Medicine|March 24, 2018
South African HIV self-testing policy and guidance considerationsFrancois Venter, Mohammed Majam, Lauren Jankelowitz, et al.
AIDS Research and Human Retroviruses|November 25, 2010
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern AfricaMatt A Price, Carole L Wallis, Shabir Lakhi, et al.
Histopathology|February 28, 2023
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortiumYasodha Natkunam, Daphne de Jong, Pedro Farinha, et al.
Pageof 30